Esther Elphick
Psychiatry · Tallahassee, FLNPI 1184834780
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,836 and has fallen 87.9% since, to $221 in 2025.
Across 215 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$538
- Neurocrine Biosciences, Inc.$495
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$468
- Teva Pharmaceuticals USA, Inc.$356
- Takeda Pharmaceuticals U.S.A., Inc.$347
- Lundbeck LLC$293
- plus $2K from 16 others
What the payments were for
- Food & beverage$4,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 28 | $538 |
| Neurocrine Biosciences, Inc. | 12 | $495 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $468 |
| Teva Pharmaceuticals USA, Inc. | 18 | $356 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $347 |
| Lundbeck LLC | 13 | $293 |
| Vanda Pharmaceuticals Inc. | 11 | $254 |
| AbbVie | 18 | $215 |
| Axsome Therapeutics, Inc. | 8 | $198 |
| Alkermes, Inc. | 8 | $172 |
| Corium, LLC | 8 | $148 |
| Eisai Inc. | 6 | $138 |
| Almatica Pharma LLC | 8 | $134 |
| Sunovion Pharmaceuticals Inc. | 7 | $134 |
| Ironshore Pharmaceuticals Inc. | 6 | $127 |
| Johnson & Johnson | 5 | $113 |
| Supernus Pharmaceuticals, Inc. | 5 | $91 |
| Merck | 5 | $88 |
| Bausch Health US, LLC | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Neos Therapeutics, LP | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$120
How this compares
$4,426 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Tallahassee
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.